Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of ...

Bausch Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of visi ...

Dear Savvy Senior, What all does Medicare cover when it comes to vision care? I currently have good vision insurance through my employer but will lose it when I retire. Almost 65 Dear Almost, Many ...

The global cataract surgery device market is poised for significant growth, projected to expand from USD 8,928 million in 2024 to an estimated USD 12,472.70 million by 2034. This robust increase, ...

The initial attempts involved the creation of multifocal lenses that have concentric ... previously could not be corrected with an intraocular lens such as astigmatism. Future lens implants ...

EPS, expectations were $0.03. Operator: Good morning, and welcome to Bausch + Lomb’s First Quarter 2025 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note ...

The FDA elevated a recall of intraocular lenses currently being wrapped up by Bausch + Lomb, following increased reports of ...

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

Patients with astigmatism above 1.5 D or against-the-rule astigmatism had significantly less residual astigmatism with toric ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.